We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
AstraZeneca has announced results from a study that show its cholesterol-lowering drug Crestor reversed atherosclerosis — plaque buildup in the arteries of patients with symptoms of coronary artery disease.